Synergistic Activity for Natural and Synthetic Inhibitors of Angiogenesis Induced by Murine Sarcoma L-1 and Human Kidney Cancer Cells.

[1]  C. Tournigand,et al.  Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials , 2017, Investigational New Drugs.

[2]  R. Figlin,et al.  Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma , 2016, Journal of Immunotherapy for Cancer.

[3]  T. Powles,et al.  Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial. , 2016, The Lancet. Oncology.

[4]  J. Brugarolas,et al.  Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma , 2016, Molecular and Cellular Biology.

[5]  D. Mcclements,et al.  Proanthocyanidins, Isolated from Choerospondias axillaris Fruit Peels, Exhibit Potent Antioxidant Activities in Vitro and a Novel Anti-angiogenic Property in Vitro and in Vivo. , 2016, Journal of agricultural and food chemistry.

[6]  D. Ribatti.  Tumor refractoriness to anti-VEGF therapy , 2016, Oncotarget.

[7]  R. Motzer,et al.  Quality‐adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma , 2016, Cancer.

[8]  Hassan Y. Ebrahim,et al.  Discovery of Novel Antiangiogenic Marine Natural Product Scaffolds , 2016, Marine drugs.

[9]  Jianfeng Zhou,et al.  Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect. , 2016, Current medicinal chemistry.

[10]  한용문.  Chlorogenic acid , 2020, Reactions Weekly.

[11]  H. Shibata,et al.  Targeting the NF-κB Pathway as a Combination Therapy for Advanced Thyroid Cancer , 2015, PloS one.

[12]  Hyo-Jong Lee,et al.  Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway , 2015, Cellular Oncology.

[13]  H. Khaza’ai,et al.  Synergistic action of compounds isolated from the hexane extract of Ardisia crispa root against tumour-promoting effect, in vitro , 2014, Natural product research.

[14]  R. Meshram,et al.  Angiogenic factors as potential drug target: efficacy and limitations of anti-angiogenic therapy. , 2014, Biochimica et biophysica acta.

[15]  N. Sugimoto,et al.  Theobromine, the Primary Methylxanthine Found in Theobroma cacao, Prevents Malignant Glioblastoma Proliferation by Negatively Regulating Phosphodiesterase-4, Extracellular Signal-regulated Kinase, Akt/mammalian Target of Rapamycin Kinase, and Nuclear Factor-Kappa B , 2014, Nutrition and cancer.

[16]  Jingyu Yang,et al.  Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling , 2013, British Journal of Cancer.

[17]  U. Demkow,et al.  Aloe arborescens and American cranberry ( Vaccinium macrocarpon ) extracts inhibit tumor-induced cutaneous angiogenesis in mice , 2013 .

[18]  J. Kocik,et al.  Inhibitory Effect of Herbal Remedy PERVIVO and Anti-Inflammatory Drug Sulindac on L-1 Sarcoma Tumor Growth and Tumor Angiogenesis in Balb/c Mice , 2013, Mediators of inflammation.

[19]  Xi Chen,et al.  Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP/PKG Pathway to Suppress Wnt/β-Catenin Signaling , 2013, Molecular Cancer Therapeutics.

[20]  N. Zaffaroni,et al.  Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models. , 2013, Biochemical pharmacology.

[21]  J. Sohn,et al.  Chlorogenic Acid Decreases Retinal Vascular Hyperpermeability in Diabetic Rat Model , 2013, Journal of Korean medical science.

[22]  J. Kocik,et al.  Experimental immunology The effect of Rhodiola kirilowii extracts on tumor-induced angiogenesis in mice , 2012 .

[23]  Xi Chen,et al.  A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity , 2012, Cancer Prevention Research.

[24]  G. Melillo,et al.  Role of the VEGF/VEGFR axis in cancer biology and therapy. , 2012, Advances in cancer research.

[25]  R. Zdanowski,et al.  In vivo effect of two complex herbal remedies Echinasal and Bioaron C on antibody production and immunological angiogenesis in mice , 2011 .

[26]  J. Gołąb,et al.  [Antitumor effects of sulindac in ovarian cell cultures]. , 2011, Ginekologia polska.

[27]  Mandip Singh,et al.  Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. , 2011, Lung cancer.

[28]  Kristina M. Cook,et al.  Angiogenesis Inhibitors: Current Strategies and Future Prospects , 2010, CA: a cancer journal for clinicians.

[29]  J. Sohn,et al.  The Anti-angiogenic Effect of Chlorogenic Acid on Choroidal Neovascularization , 2010, Korean journal of ophthalmology : KJO.

[30]  E. Skopińska-Różewska,et al.  The effect of undecanones and their derivatives on tumor angiogenesis and VEGF content. , 2010, Polish journal of veterinary sciences.

[31]  Haiquan Chen,et al.  Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction , 2009, Journal of experimental & clinical cancer research : CR.

[32]  Helen X. Chen,et al.  Adverse effects of anticancer agents that target the VEGF pathway , 2009, Nature Reviews Clinical Oncology.

[33]  A. Albini,et al.  Anti-FGF 2 approaches as a strategy to compensate resistance to anti-VEGF therapy : long-pentraxin 3 as a novel antiangiogenic FGF 2-antagonist , 2009 .

[34]  J. Liou,et al.  Nonsteroidal Anti-Inflammatory Drugs Induced Endothelial Apoptosis by Perturbing Peroxisome Proliferator-Activated Receptor-δ Transcriptional Pathway , 2008, Molecular Pharmacology.

[35]  S. Giordano,et al.  From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. , 2008, Current medicinal chemistry.

[36]  P. Kloetzel,et al.  Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma , 2007, European journal of haematology.

[37]  E. Skopińska-Różewska,et al.  Experimental immunology Sarcoma L-1 in mice as a model for the study of experimental angiogenesis , 2007 .

[38]  D. Hicklin,et al.  Targeting the Vascular Endothelial Growth Factor Pathway in the Treatment of Human Malignancy , 2007, Immunological investigations.

[39]  Ting-Chao Chou,et al.  Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies , 2006, Pharmacological Reviews.

[40]  S. Flis,et al.  Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest. , 2006, Anticancer research.

[41]  G. Mclaughlin,et al.  Adenosine receptor antagonism in acute tacrolimus toxicity. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  H. Verheul,et al.  Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology. , 2006, Current pharmaceutical design.

[43]  I. Holen,et al.  Mechanisms of Disease: preclinical reports of antineoplastic synergistic action of bisphosphonates , 2006, Nature Clinical Practice Oncology.

[44]  S. Sagar,et al.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 2 , 2006, Current oncology.

[45]  S. Sagar,et al.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer—Part 1 , 2006, Current oncology.

[46]  Won-Hwan Park,et al.  A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. , 2005, Life sciences.

[47]  C. Kandaswami,et al.  The antitumor activities of flavonoids. , 2005, In vivo.

[48]  U. Demkow,et al.  Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. , 2004, International journal of molecular medicine.

[49]  D. Coppola,et al.  Inhibition of Angiogenesis by Aβ Peptides , 2004, Angiogenesis.

[50]  M. Furmanowa,et al.  The effect of acetylshikonin isolated from Lithospermum canescens roots on tumor-induced cutaneous angiogenesis. , 2004, Acta poloniae pharmaceutica.

[51]  P. Legrand,et al.  Natural Alkylglycerols Restrain Growth and Metastasis of Grafted Tumors in Mice , 2004, Nutrition and cancer.

[52]  Y. Zhen,et al.  [Novobiocin inhibits angiogenesis and shows synergistic effect with vincristine]. , 2003, Yao xue xue bao = Acta pharmaceutica Sinica.

[53]  J. Spławiński,et al.  Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane. , 2003, Hybridoma and hybridomics.

[54]  U. Demkow,et al.  Inhibitory effect of Greenland shark liver oil combined with squalen and arctic birch ashes on angiogenesis and L-1 sarcoma growth in Balb/c mice. , 2003, Polish journal of veterinary sciences.

[55]  A. Klein-Szanto,et al.  Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis. , 2001, Cancer research.

[56]  C. Haanen.  Sulindac and its derivatives: a novel class of anticancer agents. , 2001, Current opinion in investigational drugs.

[57]  K. Alitalo,et al.  Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis , 2000, Oncogene.

[58]  E. Skopińska-Różewska,et al.  Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. , 2000, Oncology reports.

[59]  E. Skopińska-Różewska,et al.  Inhibitory effect of shark liver oil on cutaneous angiogenesis induced in Balb/c mice by syngeneic sarcoma L-1, human urinary bladder and human kidney tumour cells. , 1999, Oncology reports.

[60]  H. Fujiki,et al.  Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. , 1999, Cancer research.

[61]  E. Skopińska-Różewska,et al.  Inhibitory effect of theobromine on induction of angiogenesis and VEGF mRNA expression in v-raf transfectants of human urothelial cells HCV-29. , 1998, International journal of molecular medicine.

[62]  E. Skopińska-Różewska,et al.  The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. , 1998, Oncology reports.

[63]  O. Volpert,et al.  The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo. , 1998, Cancer investigation.

[64]  G. Piazza,et al.  Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties. , 1998, International journal of tissue reactions.

[65]  W. Hunter,et al.  The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo , 1998, Cancer Chemotherapy and Pharmacology.

[66]  H. Lee,et al.  cAMP‐dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation , 1997, Journal of cellular biochemistry.

[67]  Y. Hashimoto,et al.  Flavonoid-mediated tumor growth suppression demonstrated by in vivo study. , 1996, Cancer biotherapy & radiopharmaceuticals.

[68]  K. Roszkowski,et al.  Effect of purinergic receptor antagonists suramin and theobromine on tumor-induced angiogenesis in BALB/c mice. , 1993, Folia biologica.

[69]  S. Moodie,et al.  Effects of cyclic nucleotides and phorbol myristate acetate on proliferation of pig aortic endothelial cells , 1991, British journal of pharmacology.

[70]  F. Murad,et al.  Forskolin, phosphodiesterase inhibitors, and cyclic AMP analogs inhibit proliferation of cultured bovine aortic endothelial cells , 1986, Journal of cellular physiology.

[71]  P. Janik.  Lung colony assay in normal, irradiated and tumor bearing mice. , 1976, Neoplasma.

[72]  J. Brohult,et al.  Biochemical effects of alkoxyglycerols and their use in cancer therapy. , 1970, Acta chemica Scandinavica.